文献速递神经技术与安全MR

在神经重症监护室中应用侦察加速运动估计与还原(SAMER)运动校正二维T2加权TSE 3T脑MRI的临床评估

Clinical Evaluation of Scout Accelerated Motion Estimation and Reduction (SAMER) Motion-Corrected 2D T2-Weighted TSE 3T Brain MRI in the Neurologic Intensive Care Unit.
PubMed 文献 · AJNR Am J Neuroradiol · 2026-04-02

这项前瞻性单中心研究纳入275例在神经重症监护室3T MRI上接受脑MRI的患者,评估SAMER回顾性运动校正对轴位二维T2加权TSE序列运动伪影的改善效果;两位放射科医师盲法评分显示运动评分显著降低,另两位神经放射科医师头对头比较中SAMER校正图像在22%-23%的病例中被优先选择,原始图像被优先选择的比例低于2%。

要点

  • SAMER校正后平均运动评分从0.79降至0.62(评分者1)和从0.68降至0.52(评分者2),均P<.001。
  • 头对头比较中SAMER校正图像在22%-23%病例被优先选择,原始图像被优先选择低于2%。
  • 运动伪影减少的评分者间一致性为中等(κ=0.61),整体图像质量为一般(κ=0.39)。

核心结论

  • SAMER可显著减少神经重症监护室中二维T2加权TSE脑MRI的运动伪影并提高诊断图像质量,方法在多评分者间可靠、可无缝整合入临床工作流程且无需额外硬件,但需进一步研究以优化极端运动条件和额外MRI序列下的表现。

研究设计与样本

  • 前瞻性单中心研究,纳入2024年3月至9月在神经重症监护室3T MRI扫描仪上接受脑MRI的275例患者,每例接受嵌入SAMER运动校正框架的T2加权TSE序列;由2名经验丰富的放射科医师盲法随机对校正前后单序列应用运动分级量表评分,另由2名神经放射科医师对原始与校正图像进行头对头偏好测试;统计分析包括Wilcoxon符号秩检验、组内相关系数(ICC)和Cohen kappa一致性评分。

诊断标准与关键数值

  • 运动分级量表评分:校正后平均运动评分从0.79降至0.62(评分者1)和从0.68降至0.52(评分者2),均P<.001。
  • ICC:原始图像评分为0.92,校正后评分为0.90,评分者间信度均优秀。
  • 头对头偏好:SAMER校正图像在22%-23%的病例中被优先选择,原始图像被优先选择低于2%。
  • Cohen kappa:运动伪影减少的评分者间一致性为中等(κ=0.61),整体图像质量为一般(κ=0.39)。

局限性

  • 少数病例出现意外结果,如运动评分增加或校正不均匀,提示需进一步改进。
  • 需进一步研究以优化极端运动条件下的表现并扩展至其他MRI序列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: Patient motion remains a major source of image degradation in clinical MRI, particularly in acute and inpatient settings. We evaluated the clinical effectiveness of the Scout Accelerated Motion Estimation and Reduction (SAMER) method for retrospective motion correction in axial 2D T2-weighted TSE brain MRI, particularly in emergency and inpatient neurologic settings, where patient motion commonly degrades image quality.

MATERIALS AND METHODS: This prospective single-center study included 275 patients undergoing brain MRI on a 3T MRI scanner located in the neurologic intensive care unit between March and September 2024. Each patient received a T2-weighted TSE sequence embedded with the SAMER motion correction framework. Motion artifacts were assessed using 2 approaches in a blinded, randomized fashion: 1) a motion grading scale applied to individual image series before and after SAMER correction by 2 experienced radiologists, and 2) a head-to-head preference test comparing original and motion-corrected images, evaluated by 2 additional neuroradiologists. Statistical analysis included the Wilcoxon signed rank test, intraclass correlation coefficients (ICC), and Cohen kappa agreement scores.

RESULTS: Motion scores improved significantly after SAMER correction, with average motion grades reduced from 0.79 to 0.62 (Rater 1) and 0.68 to 0.52 (Rater 2) (P < .001 for both). For cases exhibiting at least minimal motion, the improvement was even more pronounced. ICCs were high for both original (0.92) and postcorrection (0.90) ratings, indicating excellent interrater reliability. In the head-to-head comparison, SAMER-corrected images were preferred in 22%-23% of cases, with the original images preferred in fewer than 2%. Cohen kappa showed moderate interrater agreement (κ = 0.61) for motion artifact reduction and fair agreement (κ = 0.39) for overall image quality. A small subset of cases exhibited unexpected results, such as increased motion scores or inhomogeneous correction, suggesting areas for further refinement.

CONCLUSIONS: SAMER significantly reduces motion artifacts in 2D T2-weighted TSE brain MRI performed in the neurologic intensive care unit, improving diagnostic image quality. The method is reliable across multiple raters, integrates seamlessly into clinical workflows, and offers a promising motion correction solution without additional hardware requirements. Further research is warranted to optimize performance under extreme motion conditions and across additional MRI sequences.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Hajati A, Chiang CH, Buathong S, et al. Clinical Evaluation of Scout Accelerated Motion Estimation and Reduction (SAMER) Motion-Corrected 2D T2-Weighted TSE 3T Brain MRI in the Neurologic Intensive Care Unit. AJNR Am J Neuroradiol. 2026. PMID: 41927339. doi:10.3174/ajnr.A9089

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。